Status:
UNKNOWN
Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis
Lead Sponsor:
Chongqing Medical University
Collaborating Sponsors:
Fuling Central Hospital of Chongqing City
Conditions:
Prostatitis
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether tamsulosin and tolterodine are effective in the treatment of men with lower urinary tract symptoms and chronic prostatitis/chronic pelvic pain syndrom...
Detailed Description
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common disorder in urological clinics. Most of the clinically CP/CPPS are to some extent associated with storage (irritative) symptoms, ...
Eligibility Criteria
Inclusion
- diagnosis of CP/CPPS based on the classification of US National Institutes of Health, aged 18-45 years
- total score of at least 12 on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)
- urinary score of at least 4 on the CPSI
- subjects who anticipate improving symptoms
Exclusion
- previous treatment with any other alpha-adrenergic receptor blocker and antimuscarinic agents for symptoms of CP/CPPS or for any other reason
- those who had had previous urinary tract infection with the last year
- those who had been treat or were taking medication that could affect lower urinary tract function
- those who met the criteria for chronic bacterial prostatitis after lower urinary tract localization studies
- those who had other significant medical problems
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00913315
Start Date
August 1 2009
End Date
January 1 2010
Last Update
June 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, the First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016